Search

中文 / English

Address: No. 35, Simiao Road, Daxing Biomedical Industrial Base, Zhongguancun Science Park, Daxing District, Beijing
 Copyright: Beijing Minhai Biological Technology Co., Ltd.   
Beijing ICP 10007676    Powered by  www.300.cn Beijing    Beijing Public Security No. 110115000037 Internet Drug Information Service Qualification Certificate (Beijing) Non-operating 20150173

Contact

Administrative Office: 010-59613600
Supplier consultation: 010-59613585
Recruitment: 010-59613633
Marketing: 010-59613639
Medical support: 010-59613669

Links:

Your location:
Home page
>
Development path
Page view:

      year2004

The company was established with a registered capital of 5 million yuan

    Year2009

Recognized as "National High-tech Enterprise"

Obtained medicine production license

    year2010

 

 The company was selected as the first batch of "G20 potential enterprises" in Beijing

 Company registered capital increased to 200 million yuan

 

       year2011

 

 Beijing Municipal Government awarded the "Beijing Key Laboratory of New Technology Research on Vaccine Combination"

 "Acellular Haemophilus influenzae type b combined vaccine" won the third prize of Beijing Science and Technology Award

 

 year2012

 

 Beijing Municipal Government awarded "Beijing Engineering Laboratory for New Vaccines"

 Two vaccine varieties independently developed by the company obtained GMP certificate

 Won the title of "Excellent Enterprise" in the first China Innovation and Entrepreneurship Competition

 

 year 2013

 

 The Ministry of Human Resources and Health approved the establishment of a "postdoctoral research station"

 Obtained GMP certificate for measles and rubella combined live attenuated vaccine

 

 Year 2014

 

 Beijing Municipal Science and Technology Commission recognizes "new vaccine Beijing International Science and Technology Cooperation Base"

 Beijing Science and Technology Association approved the establishment of "Academician Expert Workstation"

 Beijing Municipal Science and Technology Commission recognized "Beijing Engineering Technology Research Center for New Joint Vaccine"

 Beijing Intellectual Property Office recognized "Beijing Patent Demonstration Unit"

 Haemophilus influenzae type b conjugate vaccine (pre-filled) obtained GMP certificate

 

 2015

 

 National Development and Reform Commission recognized "National and Local Joint Engineering Laboratory for New Vaccine Development Technology"

 Passed the review of "National High-tech Enterprise"